196 related articles for article (PubMed ID: 8202508)
1. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.
Hwang CB; Horsburgh B; Pelosi E; Roberts S; Digard P; Coen DM
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5461-5. PubMed ID: 8202508
[TBL] [Abstract][Full Text] [Related]
2. Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA.
Pan D; Coen DM
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14852-7. PubMed ID: 22927407
[TBL] [Abstract][Full Text] [Related]
3. Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.
Pan D; Coen DM
J Virol; 2012 Apr; 86(8):4518-26. PubMed ID: 22301158
[TBL] [Abstract][Full Text] [Related]
4. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
Coen DM; Irmiere AF; Jacobson JG; Kerns KM
Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
[TBL] [Abstract][Full Text] [Related]
5. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.
Griffiths A; Chen SH; Horsburgh BC; Coen DM
J Virol; 2003 Apr; 77(8):4703-9. PubMed ID: 12663777
[TBL] [Abstract][Full Text] [Related]
6. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.
Griffiths A; Link MA; Furness CL; Coen DM
J Virol; 2006 Jul; 80(13):6568-74. PubMed ID: 16775343
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
8. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
Morfin F; Thouvenot D; Aymard M; Souillet G
J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
[TBL] [Abstract][Full Text] [Related]
10. Competition and complementation between thymidine kinase-negative and wild-type herpes simplex virus during co-infection of mouse trigeminal ganglia.
Chen SH; Lin YW; Griffiths A; Huang WY; Chen SH
J Gen Virol; 2006 Dec; 87(Pt 12):3495-3502. PubMed ID: 17098963
[TBL] [Abstract][Full Text] [Related]
11. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
Besecker MI; Furness CL; Coen DM; Griffiths A
J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
[TBL] [Abstract][Full Text] [Related]
12. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
15. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
16. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?
Horsburgh BC; Chen SH; Hu A; Mulamba GB; Burns WH; Coen DM
J Infect Dis; 1998 Sep; 178(3):618-25. PubMed ID: 9728528
[TBL] [Abstract][Full Text] [Related]
17. Penciclovir and pathogenesis phenotypes of drug-resistant Herpes simplex virus mutants.
Pelosi E; Mulamba GB; Coen DM
Antiviral Res; 1998 Jan; 37(1):17-28. PubMed ID: 9497069
[TBL] [Abstract][Full Text] [Related]
18. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
19. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains.
Kudo E; Shiota H; Naito T; Satake K; Itakura M
J Med Virol; 1998 Oct; 56(2):151-8. PubMed ID: 9746072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
